HomeIMMNOV • STO
add
Immunovia AB (publ)
Previous close
kr 0.26
Day range
kr 0.26 - kr 0.27
Year range
kr 0.19 - kr 0.75
Market cap
176.23M SEK
Avg Volume
6.77M
P/E ratio
-
Dividend yield
-
Primary exchange
STO
Market news
Financials
Income Statement
Revenue
Net income
| (SEK) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 101.00K | -57.02% |
Operating expense | 25.12M | -20.36% |
Net income | -29.74M | 41.76% |
Net profit margin | -29.45K | -35.52% |
Earnings per share | -0.10 | — |
EBITDA | -24.60M | -3.60% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (SEK) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 26.57M | -50.98% |
Total assets | 37.66M | -40.32% |
Total liabilities | 45.91M | 87.37% |
Total equity | -8.26M | — |
Shares outstanding | 306.08M | — |
Price to book | -8.77 | — |
Return on assets | -172.76% | — |
Return on capital | -413.15% | — |
Cash Flow
Net change in cash
| (SEK) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -29.74M | 41.76% |
Cash from operations | -16.11M | 7.13% |
Cash from investing | -5.69M | — |
Cash from financing | 19.11M | -45.45% |
Net change in cash | -2.70M | -115.47% |
Free cash flow | -13.92M | 22.17% |
About
Founded
2007
Website
Employees
12
